BDF Gestion Sells 1,726 Shares of Stryker Corporation $SYK

BDF Gestion lowered its stake in Stryker Corporation (NYSE:SYK) by 17.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,297 shares of the medical technology company’s stock after selling 1,726 shares during the quarter. BDF Gestion’s holdings in Stryker were worth $3,067,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Mid American Wealth Advisory Group Inc. purchased a new position in Stryker during the second quarter valued at approximately $26,000. Elevation Point Wealth Partners LLC purchased a new stake in Stryker in the 2nd quarter worth approximately $28,000. Sachetta LLC boosted its holdings in Stryker by 58.7% in the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 27 shares during the period. Kilter Group LLC purchased a new position in shares of Stryker during the 2nd quarter valued at $29,000. Finally, Howard Hughes Medical Institute bought a new position in shares of Stryker in the second quarter worth $29,000. 77.09% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Redburn Partners set a $420.00 price objective on Stryker in a research note on Thursday, September 18th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Stryker in a report on Monday. Royal Bank Of Canada reissued an “outperform” rating and set a $435.00 price objective on shares of Stryker in a report on Friday, November 14th. Rothschild Redb raised shares of Stryker to a “hold” rating in a research note on Thursday, September 18th. Finally, Sanford C. Bernstein reissued an “outperform” rating on shares of Stryker in a research note on Monday, November 3rd. Thirteen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $431.84.

Stryker Trading Up 0.6%

SYK stock opened at $355.21 on Friday. The company has a market capitalization of $135.84 billion, a PE ratio of 46.68, a price-to-earnings-growth ratio of 2.50 and a beta of 0.89. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.13 and a current ratio of 1.85. Stryker Corporation has a one year low of $329.16 and a one year high of $406.19. The company’s 50 day moving average price is $365.26 and its two-hundred day moving average price is $377.51.

Stryker (NYSE:SYK) last released its earnings results on Thursday, October 30th. The medical technology company reported $3.19 EPS for the quarter, beating the consensus estimate of $3.13 by $0.06. The company had revenue of $6.06 billion for the quarter, compared to analyst estimates of $6.04 billion. Stryker had a net margin of 12.07% and a return on equity of 24.07%. The firm’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same quarter last year, the firm earned $2.87 EPS. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. As a group, analysts predict that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be paid a $0.88 dividend. This is a boost from Stryker’s previous quarterly dividend of $0.84. The ex-dividend date of this dividend is Wednesday, December 31st. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.0%. Stryker’s dividend payout ratio is presently 44.15%.

Insider Activity at Stryker

In related news, CFO Preston Wendell Wells sold 165 shares of the firm’s stock in a transaction that occurred on Thursday, November 20th. The stock was sold at an average price of $365.88, for a total transaction of $60,370.20. Following the transaction, the chief financial officer directly owned 6,694 shares in the company, valued at $2,449,200.72. This trade represents a 2.41% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Ronda E. Stryker sold 276,173 shares of the business’s stock in a transaction that occurred on Thursday, November 6th. The shares were sold at an average price of $353.28, for a total value of $97,566,397.44. Following the completion of the sale, the director owned 2,702,108 shares of the company’s stock, valued at $954,600,714.24. The trade was a 9.27% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 522,118 shares of company stock worth $185,381,932 in the last ninety days. 5.90% of the stock is owned by company insiders.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.